FDA Approves the First Preventative Drug for HIV

Truvada is is a drug already used to treat HIV , but recently , it has been shown to dilute the risk of HIV infection . Now the FDA is approving Truvada for prophylactic use against HIV . This is a huge deal , reckon 50,000 masses in the U.S. are diagnosed with HIV every year .

manufacture by San Francisco - area biotech firm Gilead Sciences , Truvada was approved after two clinical trials which studied 2500 HIV - negative piece who wage in risky sexual behavior . Through the trial , doctors recover that the drug drastically reduce relative incidence of infection as long as subjects used the drug regularly . From the FDA announcement :

The iPrEx trial evaluated Truvada in 2,499 HIV - negative military personnel or transgendered women who have sex with man and with evidence of eminent jeopardy behavior for HIV transmission , such as inconsistent or no condom use during sex with a partner of confident or unknown HIV position , a high-pitched number of sex partners , and commutation of sexual urge for commodities . termination show Truvada was efficient in reducing the peril of HIV infection by 42 percent compared with placebo in this population . Efficacy was strongly correlate with drug attachment in this trial .

Hostinger Coupon Code 15% Off

That ’s correct , HIV contagion was trim down by almost half . Amazing .

Obviously , it ’s still too other to know just how effective the drug will be in the broader population . There are important factors — like remembering to take the pill — which are intemperate to command for . Also , this would n’t be the first clinical trial to yield inaccurate issue . Still , when the stakes are so eminent , it ’s hard not to get a little bit excited about every in of footing scientist gain . [ FDAviaTechnology Review ]

epitome viaMario7 / Shutterstock.com

Burning Blade Tavern Epic Universe